NEW YORK, March 31, 2016 -- TransPerfect, the world’s largest provider of language services and content management technology to the medical device industry, today announced the introduction of its EnCompass system for digital labeling and content management. Built on validated technology and patented processes, the EnCompass system helps medical device manufacturers reduce the costs, risk, and turnaround times for labeling translation by up to 50%, while improving quality up to 300%. For more information, visit: www.transperfect.com/meddev.
|
|||
Device makers are faced with an increasingly risky regulatory environment, decreased product cycle times, and an explosion of product content that requires output to multiple formats. To cope with this proliferation of content, manufacturers are turning to XML and component content management technology.
According to Marc Miller, Division President of TransPerfect Medical Device Solutions, “Our EnCompass system is in use with the world’s largest device manufacturers to dramatically reduce cost, risk, and turnaround. On a recent project, one of our clients used XML technology to produce over 5,000 pages of technical manuals in just eight business days!”
System ROI Within One Year…or Less!
TransPerfect’s EnCompass System is an integrated combination of modular, validated technologies and patented processes that provides device makers with remarkable cost savings and risk management for their English-language and translated content:
- Guided Authoring – Enables authors to automatically write simpler, more compact English and reuse previously translated content for lower cost and increased consistency.
- Translation Management – The system’s translation process automation component makes workflows and linguistic assets available to teams worldwide. A browser-based QC portal allows reviewers to view formatted content and make edits in real time, while maintaining compliance with an electronic audit trail.
- XML/CCMS – The system’s XML component content management module is the most widely-adopted in the medical device industry. XML helps automate publishing processes and supports a single-source information architecture for dramatic decreases in content cost, turnaround, and risk.
- Patented, ISO 13485/ISO 14971-Certified Services – TransPerfect Medical Device Solutions holds the world’s only patent for medical device translation risk management. Its unique approach to risk management ensures quality and accuracy when publishing to multilingual formats.
Notes Miller, “Versus traditional processes for document authoring, translation, and formatting, our EnCompass System is revolutionary. Because we’re converting manufacturers from highly manual to highly automated processes, system ROI is generally less than one year.”
Because XML systems drive reuse and consistency through “single source” architecture, the value of TransPerfect’s patented, ISO 13485/ISO 14971-certified translation processes are extremely important for high-quality multilingual publication—whatever the output channel.
About TransPerfect Medical Device Solutions
TransPerfect Medical Device Solutions is the specialized medical device division of TransPerfect. With annual revenues of more than $500 million, TransPerfect is the world's largest provider of language services and content management technology to the medical device industry. From offices in more than 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and EN 15038 certified across all offices. The Medical Device Solutions group is also certified to ISO 13485 and ISO 14971. For more information, please visit our website at: www.transperfect.com/meddev.
Contact: Marc H. Miller +1 617.597.1984 [email protected] www.transperfect.com/meddev


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



